Miconazolo (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Miconazolo" in Italian language version.

refsWebsite

Global rank Italian rank

11doi.org

2^nd place

7^th place

5nih.gov

4^th place

9^th place

4fda.gov

447^th place

644^th place

2asm.org

3,555^th place

2,382^nd place

2wiley.com

222^nd place

243^rd place

1acs.org

1,248^th place

1,065^th place

1elsevier.com

610^th place

820^th place

1springer.com

274^th place

393^rd place

1tandfonline.com

507^th place

821^st place

1drugbank.com

low place

4,124^th place

1s3-us-west-2.amazonaws.com

low place

3,547^th place

acs.org

pubs.acs.org

(EN) Erik F. Godefroi, Jan Heeres e Jan Van Cutsem, Preparation and antimycotic properties of derivatives of 1-phenethylimidazole, in Journal of Medicinal Chemistry, vol. 12, n. 5, 1969-09, pp. 784–791, DOI:10.1021/jm00305a014. URL consultato il 17 luglio 2023.

asm.org

journals.asm.org

(EN) Daisuke Kobayashi, Kei Kondo e Nobuyuki Uehara, Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect, in Antimicrobial Agents and Chemotherapy, vol. 46, n. 10, 2002-10, pp. 3113–3117, DOI:10.1128/AAC.46.10.3113-3117.2002. URL consultato il 17 luglio 2023.
(EN) Monika Sharma e Rajendra Prasad, The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans, in Antimicrobial Agents and Chemotherapy, vol. 55, n. 10, 2011-10, pp. 4834–4843, DOI:10.1128/AAC.00344-11. URL consultato il 17 luglio 2023.

doi.org

dx.doi.org

Gérald E. Piérard, Trinh Hermanns-Lê e Philippe Delvenne, Miconazole, a pharmacological barrier to skin fungal infections, in Expert Opinion on Pharmacotherapy, vol. 13, n. 8, 2012-06, pp. 1187–1194, DOI:10.1517/14656566.2012.687047. URL consultato il 17 luglio 2023.
Gérald E. Piérard, Trinh Hermanns-Lê e Philippe Delvenne, Miconazole, a pharmacological barrier to skin fungal infections, in Expert Opinion on Pharmacotherapy, vol. 13, n. 8, 2012-06, pp. 1187–1194, DOI:10.1517/14656566.2012.687047. URL consultato il 17 luglio 2023.
S. De Nollin e M. Borgers, An ultrastructural and cytochemical study of Candida albicans after in vitro treatment with imidazoles, in Mykosen, vol. 19, n. 9, 1976-09, pp. 317–328, DOI:10.1111/j.1439-0507.1976.tb01469.x. URL consultato il 17 luglio 2023.
(EN) Erik F. Godefroi, Jan Heeres e Jan Van Cutsem, Preparation and antimycotic properties of derivatives of 1-phenethylimidazole, in Journal of Medicinal Chemistry, vol. 12, n. 5, 1969-09, pp. 784–791, DOI:10.1021/jm00305a014. URL consultato il 17 luglio 2023.
(EN) E.H. Taudorf, G.B.E. Jemec e R.J. Hay, Cutaneous candidiasis – an evidence‐based review of topical and systemic treatments to inform clinical practice, in Journal of the European Academy of Dermatology and Venereology, vol. 33, n. 10, 2019-10, pp. 1863–1873, DOI:10.1111/jdv.15782. URL consultato il 17 luglio 2023.
(EN) Daisuke Kobayashi, Kei Kondo e Nobuyuki Uehara, Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect, in Antimicrobial Agents and Chemotherapy, vol. 46, n. 10, 2002-10, pp. 3113–3117, DOI:10.1128/AAC.46.10.3113-3117.2002. URL consultato il 17 luglio 2023.
(EN) Karin Thevissen, Kathryn R. Ayscough e An M. Aerts, Miconazole Induces Changes in Actin Cytoskeleton prior to Reactive Oxygen Species Induction in Yeast, in Journal of Biological Chemistry, vol. 282, n. 30, 2007-07, pp. 21592–21597, DOI:10.1074/jbc.M608505200. URL consultato il 17 luglio 2023.
(EN) Monika Sharma e Rajendra Prasad, The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans, in Antimicrobial Agents and Chemotherapy, vol. 55, n. 10, 2011-10, pp. 4834–4843, DOI:10.1128/AAC.00344-11. URL consultato il 17 luglio 2023.
(EN) Ruth E. Stevens, Julraht Konsil e Sonya S. Verrill, Bioavailability Study of a 1200 mg Miconazole Nitrate Vaginal Ovule in Healthy Female Adults, in The Journal of Clinical Pharmacology, vol. 42, n. 1, 2002-01, pp. 52–60, DOI:10.1177/0091270002042001006. URL consultato il 17 luglio 2023.
(EN) Monika Schäfer-Korting, H. C. Korting e W. Rittler, Influence of serum protein binding on theIn Vitro activity of anti-fungal agents, in Infection, vol. 23, n. 5, 1995-09, pp. 292–297, DOI:10.1007/BF01716289. URL consultato il 17 luglio 2023.
(EN) Zheqin Hu, Juan Zhang e Xiangrong Cheng, Antifungal efficiency of miconazole and econazole and the interaction with transport protein: A comparative study, in Pharmaceutical Biology, vol. 53, n. 2, 2015-02, pp. 251–261, DOI:10.3109/13880209.2014.914232. URL consultato il 17 luglio 2023.

drugbank.com

go.drugbank.com

Miconazole, su go.drugbank.com. URL consultato il 17 luglio 2023.

elsevier.com

linkinghub.elsevier.com

(EN) Karin Thevissen, Kathryn R. Ayscough e An M. Aerts, Miconazole Induces Changes in Actin Cytoskeleton prior to Reactive Oxygen Species Induction in Yeast, in Journal of Biological Chemistry, vol. 282, n. 30, 2007-07, pp. 21592–21597, DOI:10.1074/jbc.M608505200. URL consultato il 17 luglio 2023.

fda.gov

accessdata.fda.gov

FDA Approved Drug Products: Oravig (miconazole) buccal tablet (PDF), su accessdata.fda.gov.
FDA Approved Drug Products: Vusion (miconazole nitrate, zinc oxide, white petrolatum) topical ointment (PDF), su accessdata.fda.gov.
FDA Approved Drug Products: miconazole nitrate suppositories and cream (PDF), su accessdata.fda.gov.
FDA Approved Drug Products: Monistat (miconazole nitrate) suppositories and cream (PDF), su accessdata.fda.gov.

nih.gov

pubmed.ncbi.nlm.nih.gov

Gérald E. Piérard, Trinh Hermanns-Lê e Philippe Delvenne, Miconazole, a pharmacological barrier to skin fungal infections, in Expert Opinion on Pharmacotherapy, vol. 13, n. 8, 2012-06, pp. 1187–1194, DOI:10.1517/14656566.2012.687047. URL consultato il 17 luglio 2023.
Gérald E. Piérard, Trinh Hermanns-Lê e Philippe Delvenne, Miconazole, a pharmacological barrier to skin fungal infections, in Expert Opinion on Pharmacotherapy, vol. 13, n. 8, 2012-06, pp. 1187–1194, DOI:10.1517/14656566.2012.687047. URL consultato il 17 luglio 2023.
S. De Nollin e M. Borgers, An ultrastructural and cytochemical study of Candida albicans after in vitro treatment with imidazoles, in Mykosen, vol. 19, n. 9, 1976-09, pp. 317–328, DOI:10.1111/j.1439-0507.1976.tb01469.x. URL consultato il 17 luglio 2023.
L. Tanenbaum, C. Anderson e M. J. Rosenberg, 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor. A double-blind, multicenter study, in Archives of Dermatology, vol. 120, n. 2, 1984-02, pp. 216–219. URL consultato il 17 luglio 2023.

dailymed.nlm.nih.gov

DailyMed miconazole nitrate, su dailymed.nlm.nih.gov.

s3-us-west-2.amazonaws.com

Material Safety Data Sheet - Miconazole MSDS, su s3-us-west-2.amazonaws.com.

springer.com

link.springer.com

(EN) Monika Schäfer-Korting, H. C. Korting e W. Rittler, Influence of serum protein binding on theIn Vitro activity of anti-fungal agents, in Infection, vol. 23, n. 5, 1995-09, pp. 292–297, DOI:10.1007/BF01716289. URL consultato il 17 luglio 2023.

tandfonline.com

(EN) Zheqin Hu, Juan Zhang e Xiangrong Cheng, Antifungal efficiency of miconazole and econazole and the interaction with transport protein: A comparative study, in Pharmaceutical Biology, vol. 53, n. 2, 2015-02, pp. 251–261, DOI:10.3109/13880209.2014.914232. URL consultato il 17 luglio 2023.

wiley.com

onlinelibrary.wiley.com

(EN) E.H. Taudorf, G.B.E. Jemec e R.J. Hay, Cutaneous candidiasis – an evidence‐based review of topical and systemic treatments to inform clinical practice, in Journal of the European Academy of Dermatology and Venereology, vol. 33, n. 10, 2019-10, pp. 1863–1873, DOI:10.1111/jdv.15782. URL consultato il 17 luglio 2023.

doi.wiley.com

(EN) Ruth E. Stevens, Julraht Konsil e Sonya S. Verrill, Bioavailability Study of a 1200 mg Miconazole Nitrate Vaginal Ovule in Healthy Female Adults, in The Journal of Clinical Pharmacology, vol. 42, n. 1, 2002-01, pp. 52–60, DOI:10.1177/0091270002042001006. URL consultato il 17 luglio 2023.